Praxis Precision Medicines (PRAX) Non-Current Assets (2019 - 2026)

Praxis Precision Medicines' Non-Current Assets history runs 8 years deep, the most recent figure standing at $662.4 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 356.34% year-over-year to $662.4 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 245.23% YoY), while the FY2025 annual figure was $327.0 million, up 315.3% from the prior year.
• Non-Current Assets for Q1 2026 stood at $662.4 million, up from $327.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $662.4 million in Q1 2026, with the low at $3.1 million in Q4 2023.
• The 5-year median for Non-Current Assets is $38.6 million (2024), against an average of $99.7 million.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets decreased 28.45% in 2023, then jumped 2466.43% in 2024.
• Praxis Precision Medicines' Non-Current Assets stood at $4.3 million in 2022, then decreased by 28.45% to $3.1 million in 2023, then surged by 2466.43% to $78.7 million in 2024, then soared by 315.3% to $327.0 million in 2025, then soared by 102.58% to $662.4 million in 2026.
• Business Quant data shows PRAX's Non-Current Assets at $662.4 million in Q1 2026, $327.0 million in Q4 2025, and $122.5 million in Q3 2025.